Testosterone and ED Medications: Why the Combination Is More Complicated Than Most Men Assume

There is a widely held assumption among men pursuing treatment for erectile dysfunction that testosterone is the foundational variable—that if levels are optimized, everything else will follow. This belief has fueled explosive growth in testosterone replacement therapy (TRT) clinics across the United States, and with it, a growing cohort of men who are simultaneously using TRT and prescription ED medications without a clear clinical rationale for doing so.

The reality is considerably more nuanced. Testosterone and erectile function are related, but they are not interchangeable variables. Understanding the distinction between hormonal, vascular, and psychological causes of ED is not merely academic—it directly determines whether your current treatment approach is working with your physiology or against it.

The Biological Relationship Between Testosterone and Erectile Function

Testosterone does influence erectile function, but not in the direct mechanical way that many men assume. The hormone primarily governs libido—the psychological desire for sexual activity—as well as the sensitivity of penile tissue to nitric oxide, the signaling molecule that initiates the vascular cascade underlying an erection.

However, the actual mechanics of an erection are predominantly vascular. Nitric oxide triggers smooth muscle relaxation in the corpus cavernosum, allowing arterial blood to fill the erectile chambers. ED medications such as sildenafil and tadalafil work by inhibiting the enzyme PDE5, which would otherwise break down the cyclic GMP that sustains this blood flow.

This means that even a man with optimal testosterone levels can experience erectile dysfunction if his vascular system is compromised—and conversely, a man with low testosterone may have structurally intact vascular function but simply lack the motivational drive to initiate sexual activity.

When Low Testosterone Is the Actual Problem

Clinically confirmed hypogonadism—typically defined as a total testosterone level below 300 ng/dL in conjunction with symptoms—does warrant medical intervention. In these cases, TRT can restore libido and, in some men, partially restore erectile function by improving nitric oxide sensitivity in penile tissue.

However, the critical qualifier is "clinically confirmed." A significant number of men pursuing TRT in the United States do so based on direct-to-consumer testing, telemedicine consultations that may not include comprehensive evaluation, or simply on the basis of feeling fatigued or experiencing reduced sexual confidence—symptoms that have many non-hormonal explanations.

If erectile dysfunction is your primary complaint and your testosterone falls within the normal clinical range, TRT is unlikely to resolve it. More importantly, initiating TRT without a genuine clinical indication introduces a set of risks—including erythrocytosis, suppression of endogenous testosterone production, and cardiovascular strain—that may outweigh any perceived benefit.

Why Men on TRT Still Struggle With Erectile Function

This is one of the most common and underaddressed clinical scenarios: a man begins TRT, reports improved energy and libido, but continues to experience unreliable erections. He then adds an ED medication, sometimes without physician guidance. The erections improve somewhat, but not completely. He wonders whether his dosage needs adjustment, or whether he needs a different medication.

What he may not have been told is that TRT, particularly when administered via injection or topical gel, does not operate with the precision of a pharmaceutical switch. Testosterone converts to estradiol through the aromatase enzyme, and elevated estradiol in men is independently associated with erectile dysfunction. Some TRT protocols address this with aromatase inhibitors; many do not.

Additionally, TRT does not address the vascular component of ED. If a patient has underlying endothelial dysfunction—common in men with diabetes, hypertension, or metabolic syndrome—optimizing testosterone will not repair compromised arterial flow to the penis. In this context, the ED medication is doing the necessary work, and the TRT is addressing a separate, potentially unrelated variable.

The Psychological Dimension That Often Goes Unacknowledged

Performance anxiety, relationship stress, depression, and generalized anxiety disorder are among the most prevalent contributors to erectile dysfunction in men under 50. These conditions do not respond to either testosterone or PDE5 inhibitors in any direct pharmacological sense.

Yet many men—and some prescribers—pursue hormonal and pharmaceutical solutions without first conducting a thorough psychological assessment. The result is polypharmacy in service of a problem that may be primarily cognitive or relational in origin. This does not mean the dysfunction is "not real"—psychogenic ED is physiologically genuine and clinically significant. It simply means that the correct treatment pathway may involve a different discipline entirely.

How to Have a More Productive Conversation With Your Prescriber

If you are currently on TRT, taking an ED medication, or considering either, the following questions can help structure a more clinically productive conversation:

On testosterone:

• What is my current total and free testosterone level, and does it fall below the clinical threshold for hypogonadism?
• Has my estradiol level been measured, and is it within range?
• Has my LH and FSH been checked to distinguish primary from secondary hypogonadism?

On erectile function specifically:

• Has a vascular cause been evaluated—including blood pressure, lipid panel, and fasting glucose?
• Has psychological screening been conducted, including for depression and performance anxiety?
• Is the ED situational (occurring in some contexts but not others) or consistent?

On combining treatments:

• Is there a documented clinical rationale for using both TRT and an ED medication concurrently?
• Are there any known interactions between my specific TRT formulation and my ED prescription?
• What outcome metrics should I use to evaluate whether the current approach is working?

What the Research Actually Shows

A body of clinical literature supports the use of TRT in genuinely hypogonadal men to improve sexual function, with some studies showing that TRT alone can restore adequate erectile function without the addition of a PDE5 inhibitor. Other research indicates that the combination of TRT and a PDE5 inhibitor produces superior outcomes in hypogonadal men compared to either treatment alone.

What the evidence does not support is the use of TRT as a first-line or standalone treatment for ED in eugonadal men—those with normal testosterone levels. In this population, TRT carries risk without commensurate benefit, and the underlying driver of ED remains unaddressed.

Conclusion: Precision Matters More Than Optimization

The appeal of testosterone as a solution to erectile dysfunction is understandable. It is a tangible, measurable variable that men can act upon, and the direct-to-consumer wellness industry has invested heavily in positioning it as the master regulator of male sexual health. But clinical reality is less tidy.

Effective ED treatment begins with an accurate diagnosis. Whether the etiology is hormonal, vascular, psychological, or—most commonly—a combination of all three, the treatment approach should follow the evidence, not the marketing. A prescriber who takes the time to distinguish between these pathways will serve you far better than one who reflexively combines treatments without a clear diagnostic rationale.